Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK of Ceftaroline in Critical Care Pneumonia
NCT03025841Phase 1Completed
- Sponsor
- CHU de Poitiers
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ceftaroline fosamil in pneumonia, sponsored by CHU de Poitiers. Primary endpoints: Minimum plasma concentration of Ceftaroline at Day 6, Maximum plasma concentration of Ceftaroline at Day 6 and 3 more. Started Dec 2016; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT03025841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025841.